Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: A systematic review

Journal of the American College of Cardiology

Volumn 63, Issue 25 PART A, 2014, Pages 2751-2768

  Thavendiranathan, Paaladinesh ^a,b   Poulin, Frédéric ^a   Lim, Ki Dong ^a   Plana, Juan Carlos ^c   Woo, Anna ^a   Marwick, Thomas H ^d  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

cardiotoxicity; chemotherapy; speckle tracking echocardiography; tissue Doppler

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; IDARUBICIN; REACTIVE OXYGEN METABOLITE; TRASTUZUMAB; TROPONIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADJUVANT THERAPY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOTOXICITY; CASE CONTROL STUDY; CHILDHOOD CANCER; COHORT ANALYSIS; DRUG DOSE COMPARISON; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; LOW DRUG DOSE; MULTIPLE CANCER; MYOCARDIAL DEFORMATION; MYOCARDIAL DISEASE; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PEAK SYSTOLIC GLOBAL CIRCUMFERENTIAL STRAIN; PEAK SYSTOLIC GLOBAL LONGITUDINAL STRAIN; PEER REVIEW; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPECKLE TRACKING ECHOCARDIOGRAPHY; SYSTEMATIC REVIEW; TISSUE DOPPLER IMAGING; TREATMENT DURATION; BIOMECHANICS; CARDIOVASCULAR PARAMETERS; DOPPLER ECHOCARDIOGRAPHY; MULTIPLE CYCLE TREATMENT; MYOCARDIAL STRAIN; PROGNOSIS; TREATMENT OUTCOME;

CARDIOTOXICITY; CHEMOTHERAPY; SPECKLE TRACKING ECHOCARDIOGRAPHY; TISSUE DOPPLER;

ANTINEOPLASTIC AGENTS; CARDIOMYOPATHIES; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; HEART VENTRICLES; HUMANS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; VENTRICULAR FUNCTION;

EID: 84903142814     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.073     Document Type: Review

References (68)

1. M.P. Coleman, D. Forman, and H. Bryant et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data Lancet 377 2011 127 138
2. International Agency for Research on Cancer World Cancer Fact Sheet 2012 World Health Organization Geneva, Switzerland Available at: http://gicr.iarc.fr/ files/resources/20120906-WorldCancerFactSheet.pdf Accessed September 1, 2013
3. M.J. Hooning, A. Botma, and B.M. Aleman et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer J Natl Cancer Inst 99 2007 365 375
4. J.J. Doyle, A.I. Neugut, J.S. Jacobson, V.R. Grann, and D.L. Hershman Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study J Clin Oncol 23 2005 8597 8605
5. G.M. Felker, R.E. Thompson, and J.M. Hare et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 2000 1077 1084
6. K. Negishi, T. Negishi, B.A. Haluska, J.L. Hare, J.C. Plana, and T.H. Marwick Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection Eur Heart J Cardiovasc Imaging 15 2014 324 331
7. M.G. Khouri, P.S. Douglas, and J.R. Mackey et al. Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues Circulation 126 2012 2749 2763
8. A. Seidman, C. Hudis, and M.K. Pierri et al. Cardiac dysfunction in the trastuzumab clinical trials experience J Clin Oncol 20 2002 1215 1221
9. C.W. Yancy, M. Jessup, and B. Bozkurt et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 1495 1539
10. P. Thavendiranathan, A.D. Grant, T. Negishi, J.C. Plana, Z.B. Popovic, and T.H. Marwick Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy J Am Coll Cardiol 61 2013 77 84
11. D. Cardinale, A. Colombo, and G. Lamantia et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 2010 213 220
12. D. Cardinale, A. Colombo, and R. Torrisi et al. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation J Clin Oncol 28 2010 3910 3916
13. N. Fallah-Rad, M. Lytwyn, T. Fang, I. Kirkpatrick, and D.S. Jassal Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy J Cardiovasc Magn Reson 10 2008 5
14. M.L. Telli, S.A. Hunt, R.W. Carlson, and A.E. Guardino Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility J Clin Oncol 25 2007 3525 3533
15. D. Wadhwa, N. Fallah-Rad, and D. Grenier et al. Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study Breast Cancer Res Treat 117 2009 357 364
16. H. Geyer, G. Caracciolo, and H. Abe et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications J Am Soc Echocardiogr 23 2010 351 369 quiz 453-5
17. A. Liberati, D.G. Altman, and J. Tetzlaff et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
18. V. Mor-Avi, R.M. Lang, and L.P. Badano et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications Eur J Echocardiogr 12 2011 167 205
19. N.L. Greenberg, M.S. Firstenberg, and P.L. Castro et al. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility Circulation 105 2002 99 105
20. P.P. Sengupta, A.J. Tajik, K. Chandrasekaran, and B.K. Khandheria Twist mechanics of the left ventricle: principles and application J Am Coll Cardiol Img 1 2008 366 376
21. Y.F. Cheung, S.N. Li, G.C. Chan, S.J. Wong, and S.Y. Ha Left ventricular twisting and untwisting motion in childhood cancer survivors Echocardiography 28 2011 738 745
22. X. Bi, Y. Deng, and F. Zeng et al. Evaluation of epirubicin-induced cardiotoxicity by two-dimensional strain echocardiography in breast cancer patients J Huazhong Univ Sci Technolog Med Sci 29 2009 391 394
23. K. Takenaka, Y. Kuwada, and M. Sonoda et al. Anthracycline-induced cardiomyopathies evaluated by tissue Doppler tracking system and strain rate imaging J Cardiol 37 Suppl 1 2001 129 132
24. M. Al-Biltagi, O. Abd Rab Elrasoul Tolba, M.R. El-Shanshory, N. Abd El-Aziz El-Shitany, and E. El-Sayed El-Hawary Strain echocardiography in early detection of doxorubicin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia ISRN Pediatr 2012 2012 870549
25. C. Cadeddu, A. Piras, and G. Mantovani et al. Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment Am Heart J 160 2010 487.e1 487.e7
26. J. Ganame, P. Claus, and B. Eyskens et al. Acute cardiac functional and morphological changes after anthracycline infusions in children Am J Cardiol 99 2007 974 977
27. R. Jurcut, H. Wildiers, and J. Ganame et al. Strain rate imaging detects early cardiac effects of pegylated liposomal doxorubicin as adjuvant therapy in elderly patients with breast cancer J Am Soc Echocardiogr 21 2008 1283 1289
28. G. Mantovani, C. Madeddu, and C. Cadeddu et al. Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers Oncologist 13 2008 1296 1305
29. G. Mercuro, C. Cadeddu, and A. Piras et al. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers Oncologist 12 2007 1124 1133
30. H. Motoki, J. Koyama, and H. Nakazawa et al. Torsion analysis in the early detection of anthracycline-mediated cardiomyopathy Eur Heart J Cardiovasc Imaging 13 2012 95 103
31. J.T. Poterucha, S. Kutty, R.K. Lindquist, L. Li, and B.W. Eidem Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction J Am Soc Echocardiogr 25 2012 733 740
32. P.W. Stoodley, D.A. Richards, and A. Boyd et al. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months Eur J Cancer 49 2013 3396 3403
33. P.W. Stoodley, D.A. Richards, and A. Boyd et al. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy Eur Heart J Cardiovasc Imaging 14 2013 228 234
34. P.W. Stoodley, D.A. Richards, and R. Hui et al. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy Eur J Echocardiogr 12 2011 945 952
35. H. Wildiers, R. Jurcut, and J. Ganame et al. A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patients Crit Rev Oncol Hematol 67 2008 133 138
36. H. Zhang, W.S. Shen, C.H. Gao, L.C. Deng, and D. Shen Protective effects of salidroside on epirubicin-induced early left ventricular regional systolic dysfunction in patients with breast cancer Drugs in R&D 12 2012 101 106
37. S. Baratta, M. Damiano, and M. Marchese et al. Serum markers, conventional Doppler echocardiography and two-dimensional systolic strain in the diagnosis of chemotherapy-induced myocardial toxicity Rev Argent Cardiol 81 2013 151 158
38. A.M. Mavinkurve-Groothuis, K.A. Marcus, and M. Pourier et al. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study Eur Heart J Cardiovasc Imaging 14 2013 562 569
39. C. Mornos, and L. Petrescu Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist Can J Physiol Pharmacol 91 2013 601 607
40. H. Sawaya, I.A. Sebag, and J.C. Plana et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab Circ Cardiovasc Imaging 5 2012 596 603
41. H. Sawaya, I.A. Sebag, and J.C. Plana et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients Am J Cardiol 107 2011 1375 1380
42. K. Negishi, T. Negishi, J.L. Hare, B.A. Haluska, J.C. Plana, and T.H. Marwick Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity J Am Soc Echocardiogr 26 2013 493 498
43. J.L. Hare, J.K. Brown, R. Leano, C. Jenkins, N. Woodward, and T.H. Marwick Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab Am Heart J 158 2009 294 301
44. N. Fallah-Rad, J.R. Walker, and A. Wassef et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy J Am Coll Cardiol 57 2011 2263 2270
45. E.T. Yeh, and C.L. Bickford Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management J Am Coll Cardiol 53 2009 2231 2247
46. J. Chen, J.B. Long, A. Hurria, C. Owusu, R.M. Steingart, and C.P. Gross Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer J Am Coll Cardiol 60 2012 2504 2512
47. Y.F. Cheung, W.J. Hong, G.C. Chan, S.J. Wong, and S.Y. Ha Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy Heart 96 2010 1137 1141
48. J. Ganame, P. Claus, and A. Uyttebroeck et al. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients J Am Soc Echocardiogr 20 2007 1351 1358
49. E. Ho, A. Brown, and P. Barrett et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study Heart 96 2010 701 707
50. A.M. Mavinkurve-Groothuis, J. Groot-Loonen, and K.A. Marcus et al. Myocardial strain and strain rate in monitoring subclinical heart failure in asymptomatic long-term survivors of childhood cancer Ultrasound Med Biol 36 2010 1783 1791
51. J.H. Park, Y.H. Kim, M.C. Hyun, and H.S. Kim Cardiac functional evaluation using vector velocity imaging after chemotherapy including anthracyclines in children with cancer Korean Circ J 39 2009 352 358
52. B. Yagci-Kupeli, A. Varan, H. Yorgun, B. Kaya, and M. Buyukpamukcu Tissue Doppler and myocardial deformation imaging to detect myocardial dysfunction in pediatric cancer patients treated with high doses of anthracyclines Asia Pac J Clin Oncol 8 2012 368 374
53. W. Yu, S.N. Li, G.C. Chan, S.Y. Ha, S.J. Wong, and Y.F. Cheung Transmural strain and rotation gradient in survivors of childhood cancers Eur Heart J Cardiovasc Imaging 14 2013 175 182
54. H.K. Yu, W. Yu, D.K. Cheuk, S.J. Wong, G.C. Chan, and Y.F. Cheung New three-dimensional speckle-tracking echocardiography identifies global impairment of left ventricular mechanics with a high sensitivity in childhood cancer survivors J Am Soc Echocardiogr 26 2013 846 852
55. K. Erven, A. Florian, and P. Slagmolen et al. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy International Journal of Radiation Oncology Biology Physics 85 2013 1172 1178
56. K. Erven, R. Jurcut, and C. Weltens et al. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients International Journal of Radiation Oncology, Biology, Physics 79 2011 1444 1451
57. H.R. Tsai, O. Gjesdal, and T. Wethal et al. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy Am J Cardiol 107 2011 472 477
58. H.F. Chang, Z.R. Jiang, X.F. Wang, and Z.N. Wang Strain rate imaging in assessment of the relationship between the dose of thoracic radiotherapy and the radiotherapy-induced myocardial damage [Chinese] Chinese Journal of Medical Imaging Technology 25 2009 1032 1035
59. Y.A. Wang, G.S. Li, H.Y. Cui, and D.Z. Xia Strain rate imaging in early assessment of thoracic radiotherapy-induced myocardial damage. [Chinese] Chinese Journal of Medical Imaging Technology 22 2006 1194 1196
60. T. Eschenhagen, T. Force, and M.S. Ewer et al. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 13 2011 1 10
61. L.A. Smith, V.R. Cornelius, and C.J. Plummer et al. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials BMC Cancer 10 2010 337
62. D.J. Slamon, B. Leyland-Jones, and S. Shak et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 2001 783 792
63. M.S. Ewer, and S.M. Lippman Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity J Clin Oncol 23 2005 2900 2902
64. D. Bovelli, G. Plataniotis, F. Roila on behalf of the ESMO Guidelines Working Group Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines Ann Oncol 21 Suppl 5 2010 v277 v282
65. S.A. Hunt ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 46 2005 e1 82
66. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Eur J Heart Fail 14 2012 803 869
67. J.R. Carver, C.L. Shapiro, and A. Ng et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects J Clin Oncol 25 2007 3991 4008
68. T. Yingchoncharoen, S. Agarwal, Z.B. Popovic, and T.H. Marwick Normal ranges of left ventricular strain: a meta-analysis J Am Soc Echocardiogr 26 2013 185 191